Amy Schumer shows off dramatic weight loss in mini-dress and continues to ditch wedding ring amid divorce rumors
The 44-year-old comedian is the skinniest she’s looked in decades thanks in part to Mounjaro, the trendy GLP-1 agonist drug she began taking earlier this year to shrink her 5ft7in frame.
Warning over new fat jab side effect that could hit up to three million Brits this Christmas
CHRISTMAS will be very merry for three million fat jab users — as they are likely to get drunk quickly. Doctors have issued a festive drink warning to those using GLP-1 drugs such as Mounjaro and Ozempic. They say users will get tipsy faster and that alcohol will stay in their systems for longer, increasing…
A weight loss pill that works like Ozempic? Early data on orforglipron sparks major buzz
A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative to injectables. Clinical trials show significant weight loss and metabolic improvements, mirroring injectable efficacy. This convenient daily tablet promises better adherence and broader accessibility for individuals seeking effective obesity care, marking a significant shift in treatment delivery.
This 7% Yielder Could Be a Top AI Play
Key Points A looming patent cliff in which Pfizer will lose patent exclusivity to a handful of drugs has combined with cratering revenue from COVID-19 treatments to drive Pfizer shares down 50% since 2022. Pfizer has two important catalysts that can help it not only survive but also thrive amid these these challenges. Pfizer’s yield […]
Amy Schumer shows off dramatic weight loss in mini-dress and ditches wedding ring amid divorce rumors
The 44-year-old comedian is the skinniest she’s looked in decades thanks to the trendy GLP-1 agonist drug, Mounjaro
Weight loss drugs go from niche to mainstream – Axios
Weight loss drugs go from niche to mainstream Axios Ozempic and Other GLP-1s Are Now Being Marketed to People Who Aren’t Obese Bloomberg.com Public health should embrace GLP-1 drugs without abandoning obesity prevention statnews.com Is everyone around you microdosing Ozempic? Vogue India What we still don’t know about weight-loss drugs MIT Technology Review
Biomolecules, Vol. 15, Pages 1670: Incretin-Related Pathology and Serum Exosome Detection in Experimental Alcohol-Related Brain Damage
Biomolecules, Vol. 15, Pages 1670: Incretin-Related Pathology and Serum Exosome Detection in Experimental Alcohol-Related Brain Damage Biomolecules doi: 10.3390/biom15121670 Authors: Suzanne M. de la de la Monte Ming Tong Yiwen Yang Alcohol’s chronic neurotoxic and degenerative effects mediate alcohol-related brain damage (ARBD), which is marked by neurobehavioral, cognitive, and motor deficits. Major underlying abnormalities include […]
Weight-loss jab users are being left with debilitating new side-effect, one of the UK’s leading orthopaedic surgeons warns
The alarming trend spotted amongst GLP-1 users means some patients cannot lift their limbs due to nerve dysfunction.
RPG Life Sciences eyes GLP-1 entry, US market via plant acquisitions
The company sharpens its domestic specialty formulations focus and looks to scale APIs through acquisitions, while planning partnership-led GLP-1 launches
Why you need a GLP-1 exit plan
I’ve seen clients start GLP-1 medications full of hope, and stop them feeling betrayed by their own biology. Some reached their limit with side effects: relentless nausea, fatigue, or the quiet loss of joy in eating. Others simply couldn’t afford to stay on. A few never saw the promised results at all. But for nearly […]